–™xzv{«{Ú«{=KCS
 ˜ –¡ä
}X܇d°%0Í¨Ó&d°Ò¿&†i
Þwsv{ v{Ýl{¹½» 3BHS±‹¹½=R?S f”“
DNR:F IOR>Q
&¶Ë'%¼&²nˆ¬¨%—1
«µ$©!T|%a1
0, ¶Ë%0ˆ¬¨p&•"œŽ'¬
01'¶Ë&¨«µ$FP3!'$, ¶Ë­¬
0 ͨÓ%-0̧d°_®!0Ձ, ¶Ë¯š ͨÓ&W!, „Í_®2’
GB !ãAI6R;Ràhuman !-defensin, hBDáâcathelicidin LL-37 " psoriasin $#£·1
01.&Í¨Ó%
]¥ƒ!_®2º"¸.1
', Y)!%`®1
0¬¨Ó-/ÍÀr‚,
0, 1)!%, "[&¹½Æ hBDâ
LL-37 " psoriasin $#&Í¨Ó, Í_®\u&€‚d°Ò¿žÈ2’"2Ïg
"(, UÐ&Í¨Ó[email protected]:5B,J<BÂÇ, yWª, T ÂÇ$#&d°‘…Â
Ç2¤Šk0"%-
, 1.ÂÇ&ØÔ2Ñ~, .%ÂÇtŸ"hk, :5B8
5R+9M85R&­¬, jb¢´, ξ׎"¶ËFP3žÈ$#2Ò¿0), Í¨
ÓJ<BÂÇ2Z
ξÖي2t„, .%J<BÂÇ2ÊßÁ0!$,
,*Ñ~qz, ÉÓLA47S?S&­¬2Ò¿0
\U&".¶Ë$#&U¶ÃÄ­¬0 ͨÓ'^e!m% ͨÓ"
!$, $d°‘…ÂÇ2¤Šk0"%-
c
, Œ›Ü‡, ¦³o‰"d°Ò¿
%ÛV0"Å.10
[1] Niyonsaba F. et al.: Curr Pharm Des, 15: 2393-2413, 2009
[2] Niyonsaba F. et al.: J Immunol, 184: 3526-3534, 2010
[3] Akiyama T, Niyonsaba F et al.: J Innate Immun (In press), 2014.
[4] Kiatsurayanon C, Niyonsaba F et al.: J Invest Dermatol (In press), 2014
ダウンロード

宿主防御免疫における抗菌物質の免疫調節の役割